Intrinsic Value of S&P & Nasdaq Contact Us

Galecto, Inc. GLTO NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
53/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$43.67
+64%

Galecto, Inc. (GLTO) reported total assets of $260.53M and total liabilities of $20.15M for quarter ending 2025-12-31, resulting in total equity of $240.38M.

The company held $257.62M in cash and short-term investments. Total debt stood at $1.41M, with net debt of $-256.22M. The Debt-to-Equity (D/E) ratio was 0.01 (conservative).

Current ratio is 12.98, indicating strong short-term liquidity.

Criteria supported by this page:

  • HEALTH (100/100, Pass) — Debt-to-Equity of 0.01, current ratio of 12.98 — balance sheet is strong
  • MOAT (28/100) — Total assets $260.53M and equity $240.38M support the company's competitive scale
  • VALUE (100/100) — Debt-to-Equity 0.01 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 51/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
53/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
→ Valuation
FUTURE
73/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
28/100
Proven by this page
GROWTH
15/100
→ Income
INCOME
N/A
No coverage
Galecto, Inc. Balance Sheet History
Metric Q4 FY2025 Q3 FY2025 Q2 FY2025 Q1 FY2025
Total Assets $260.53M$10.74M$13.69M$15.37M
Total Liabilities $20.15M$4.07M$2.74M$1.66M
Total Debt $1.41M$1.41M$75K$60K
Cash & Investments $257.62M$7.61M$10.21M$11.94M
Total Stockholders Equity $240.38M$6.67M$10.95M$13.71M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message